Related Experiment Videos
Tumour therapy with genes encoding apoptin and E4orf4
Iwona Mitrus1, Ewa Missol-Kolka, Andrzej Plucienniczak
1Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.
Anticancer Research
|May 5, 2005
Summary
Gene therapy using apoptin and e4orf4 genes showed temporary tumor growth inhibition. Electroporation delivery proved inefficient for a lasting therapeutic effect in preclinical models.
Area of Science:
- Molecular Biology
- Cancer Gene Therapy
- Cell Biology
Background:
- Apoptosis-inducing genes offer potential for targeted cancer therapy.
- Selectivity for transformed cells is crucial for minimizing side effects.
- Electroporation is a method for DNA delivery into cells.
Purpose of the Study:
- To evaluate the efficacy of apoptin and e4orf4 genes in cancer gene therapy.
- To assess the suitability of electroporation for delivering these therapeutic genes.
- To investigate the in vitro and in vivo apoptotic effects of apoptin and e4orf4.
Main Methods:
- Synthesis of the apoptin gene based on published sequences.
- In vitro apoptosis assays (MTT and TUNEL) in COS-7, Renca, and B16(F10) cell lines.
- In vivo gene transfer via electroporation into murine B16(F10) tumors.
Main Results:
- Both synthesized apoptin and e4orf4 genes induced apoptosis in tested cell lines.
- Electroporation-mediated gene transfer resulted in temporary tumor growth inhibition.
- Tumor regrowth was observed upon cessation of the therapy, indicating a lack of permanent effect.
Conclusions:
- Apoptin and e4orf4 genes effectively induce apoptosis in cancer cells.
- Electroporation exhibits low efficiency for gene transfer, limiting its therapeutic impact.
- Further optimization of gene delivery methods is required for sustained gene therapy outcomes.